CPHL (Citi Pharma Ltd.) listed in PSX,ALLSHR,KMIALLSHR. CPHL share price / stock price today is 43.61 PKR. Today volume traded in CPHL is 3.07 M, price change is -0.43%, high price is 44.60 PKR, and low price is 43.50 PKR.
Return (%) | Absolute Return | ||||||
---|---|---|---|---|---|---|---|
1 Week | 1 Month | 3 Month | 6 Month | 1 Year | |||
Return | 15.43% | 22.91% | 40.81% | 76.2% | 75.42% |
Date | Announce Title | Attachments |
---|---|---|
2024-10-11 | Material Information | View PDF |
2024-10-09 | Transmission of Annual Report for the Year Ended | View PDF |
2024-10-07 | Notice of Annual General Meeting | View PDF |
2024-10-02 | Financial Results for the year ended | View PDF |
2024-10-01 | Board Meeting in Progress | View |
2024-09-23 | Board Meeting | View |
2024-09-20 | Material Information | View PDF |
2024-07-05 | Company Secretary | View |
2024-07-02 | Material Information | View PDF |
2024-05-15 | Material Information | View PDF |
2024-05-07 | Change of Company Secretary | View |
2024-05-07 | Material Information | View PDF |
2024-04-30 | Transmission of Quarterly Report for the period ended | View PDF |
2024-04-26 | Financial Results for the quarter ended | View PDF |
2024-04-25 | Board Meeting in Progress | View |
2024-04-18 | Board Meeting | View |
2024-03-04 | Transmission of Quarterly Report for Period Ended | View PDF |
2024-02-29 | Financial Results for the Quarter Ended 2023-12-31 | View PDF |
2024-02-21 | Board Meeting | View |
2023-11-13 | Dispatch of Final Dividend Warrants | View PDF |
2023-11-08 | Material Information | View PDF |
2023-10-31 | Transmission of Quarterly Report for the Period Ended September 30, 2023 | View PDF |
2023-10-30 | Financial Results for the Quarter Ended September 30, 2023 | View PDF |
2023-10-20 | Board Meeting | View |
2023-10-06 | Transmission of Annual Report for the year ended 30-06-2023 | View PDF |
2023-10-06 | Notice of Annual General Meeting | View PDF |
2023-09-28 | Financial Results for the year ended 30-06-2023 | View PDF |
2023-09-21 | Board Meeting | View |
2023-09-21 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
2023-09-21 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
2023-05-29 | Results of Board Meeting 26-05-2023 | View PDF |
2023-05-26 | Emergent Board Meeting in Progress | View |
2023-05-25 | Board Meeting | View |
2023-04-28 | Transmission of Quarterly Report for the Period ended March 31, 2023 | View PDF |
2023-04-28 | Financial Results for the 3rd Quarter ended March 31, 2023 | View PDF |
2023-04-28 | Annual Progress Report for the Period ended June 30, 2022 | View PDF |
2023-04-28 | Half Yearly Progress Report for the Period ended December 31, 2022 | View PDF |
2023-04-28 | Half Yearly Progress Report for the period ended December 31, 2021 | View PDF |
2023-04-20 | Board Meeting | View |
2023-03-01 | Transmission of Half Yearly Report for the period ended December 31, 2022 | View PDF |
2023-02-28 | Financial Results for the 2nd Quarter Ended December 31, 2022 | View PDF |
2023-02-27 | Board Meeting in Progress | View |
2023-02-20 | Board Meeting | View |
2023-01-02 | Corporate Briefing Session | View PDF |
2022-11-11 | Resolutions adopted in Annual General Meeting | View PDF |
2022-10-31 | Transmission of Quarterly Report for the Period Ended September 30, 2022 | View PDF |
2022-10-28 | Change of Management | View PDF |
2022-10-28 | Appointment of Chairman & CEO | View PDF |
2022-10-28 | Financial Results for the Quarter ended September 30, 2022 | View PDF |
2022-10-21 | Notice of Election of Directors under section 159(4) of Companies Act, 2017 | View PDF |
2022-10-21 | Board Meeting | View |
2022-10-07 | Transmission of Annual Report for the year ended June 30, 2022 | View PDF |
2022-10-07 | Notice of Annual General Meeting | View PDF |
2022-09-23 | Financial Results for the year ended June 30, 2022 | View PDF |
2022-09-16 | Board Meeting | View |
2022-04-28 | Transmission of Quarterly Report for the Period Ended March 31, 2022 | View PDF |
2022-04-12 | Board Meeting | View |
2022-02-28 | Transmission of 2nd Quarter Report for the Period ended December 31, 2021 | View PDF |
2022-02-22 | Material Information | View PDF |
2022-02-22 | Financial Results for the 2nd Quarter ended December 31, 2021 | View PDF |
2022-02-18 | Material Information | View PDF |
2022-02-11 | Board Meeting | View |
2021-12-31 | Material Information | View |
2021-12-29 | Resolutions Passed in Annual General Meeting | View PDF |
2021-11-25 | Credit of Final Cash Dividend | View |
2021-11-22 | Material Information | View |
2021-11-18 | Credit of Bonus Share Certificates | View PDF |
2021-11-01 | Transmission of Quarterly Report for the period September 30, 2021 | View PDF |
2021-10-29 | Financial Results for the first quarter ended September 30, 2021 | View PDF |
2021-10-22 | Board Meeting | View |
2021-10-07 | Transmission of Annual Report for the year ended June 30, 2021 | View PDF |
2021-10-07 | Notice of Annual General Meeting | View PDF |
2021-09-30 | Financial Results for the year ended June 30, 2021 | View PDF |
2021-09-23 | Board Meeting | View |
2021-09-16 | Material Information | View PDF |
2021-09-13 | Decisions of Baord Meeting | View PDF |
2021-08-31 | Board Meeting | View |
2021-08-13 | Decisions of the Board Meeting | View PDF |
2021-08-06 | Board Meeting | View |
2021-08-06 | Board Meeting REVOKED | View |
2021-08-06 | Board Meeting | View |
2021-08-06 | Change of Director | View |
2021-07-27 | Change of Director | View |
2021-07-14 | Material Information | View PDF |
Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.
Mr. Rizwan Ahmad | CEO |
---|---|
Mr. Nadeem Amjad | Chairman |
Mr. Muhammad Riaz | Company Secretary |
CPHL (Citi Pharma Ltd.) listed in PSX,ALLSHR,KMIALLSHR. CPHL Share Price / Stock Price is 43.61 PKR. You can also check; Share Price History, CPHLPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.
Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.
© 2024 SARMAAYA.PK